Amethyst Radiotherapy reaches the United Kingdom

Amethyst Radiotherapy expands its footprint into the UK through the acquisition of the 100% share capital of Medical Equipment Solutions Limited (MESL) – a specialised provider of intracranial radiation treatments (using the GammaKnife platform) at Queen Square Radiosurgery Centre in London and the Thornbury Radiosurgery Centre in Sheffield.

Amethyst Radiotherapy now operates twelve radiotherapy centres across six countries with a further twenty either in planning and/or development.

Group CEO, Ludovic Robert, says: “Amethyst Radiotherapy aims to build on the established reputation of Queen Square Radiosurgery Centre, London, and the Thornbury Radiosurgery Centre in Sheffield to provide the best possible, evidence based treatment for patients with previously hard to treat brain lesions.”

Adding: “Amethyst is rigorously focused on delivering the highest quality of service for patients, working in close partnership with leading NHS Centres of Excellence, Neurosurgeons and Oncologists as well as private payors and providers across the wider health economy.” Amethyst expects to further develop its service footprint across the UK. Amethyst Radiotherapy has appointed Stefan Doroszkowski to lead the UK business roll-out. Stefan has worked +25 years across the industry for a wide range of public and private payors and providers.

About Gamma Knife:* Gamma Knife is a non-invasive stereotactic radiosurgery platform that involves no scalpel or incision – it is not a knife at all. Instead, GammaKnife uses up to 201 precisely focused beams of radiation to control malignant and non-malignant tumors, as well as vascular and functional disorders in the brain, without harming surrounding healthy tissue.

Patients are typically in and out of the hospital in a day, and back to their normal routines soon after treatment. GammaKnife radiosurgery may be used in place of – or in addition to – traditional surgery or whole brain radiation, depending on a patient’s diagnosis.

* Gamma Knife is a registered trade-mark of Elekta (https://gammaknife.com/what-is-gamma-knife/). All rights reserved

1st radiotherapy treatments in stereotactic conditions at Creil clinic

On February 7th, we inaugurated radiotherapy treatments in stereotactic conditions in Creil (France). Amethyst Radiotherapy is the very first one to propose these state-of-the-art treatments in the department of Oise, hence enabling patients of the region to have their treatment delivered close to their home.

Radiotherapy in stereotactic conditions is a very high precision irradiation technique, which allows to treat with great efficiency small lung cancers and metastases (brain, lung, bone), in a limited number of sessions, often 3 to 5 and, in less than 15 days, with few side effects.

This achievement is the result of major financial investment – in a new linear accelerator and a last-generation repositioning system – combined with a strong commitment of the medical team to always provide the best possible treatments and experience for the patient.

Inauguration of new Linear Accelerator in La Garenne-Colombes

On 8th of November 2019, the center Amethyst of La Garenne-Colombes in France inaugurated its new linear accelerator and opened its premises to medical partners.

Our radiation oncologists gave a tour of the clinic installations to their peers while explaining the latest radiotherapy techniques, including radiation therapy in stereotactic conditions.

Professor Cosset focused on prostate cancer, Dr. Haie-Meder presented brachytherapy treatments and Dr. Chaurin provided an update in Ear, Nose and Throat treatments.

Amethyst New Opening: Rome

May 2017 marks the first day of the new Amethyst centre in Rome. The grow of the Amethyst network has now reached the Italian Peninsula.

Located in the picturesque Isola Tiberina, an island located inside the Tiber river, the centre stems from a partnership between Amethyst and Fatebenefratelli order, which has run the San Giovanni Calibita Hospital since 1585. The centre is located inside the hospital building. It develops around the ruins of the temple of the ancient roman god of medicine, Aesculapius.

The island has served since the III century BCE as the healthcare centre of Rome. The new investments planned by Amethyst on the site aim at creating a quality-focused, high-technology radiotherapy centre by revamping and completely renovate the existing department.

The centre is equipped with two last generation Varian Linacs complete of all accessories. A shuttle service is also available for all people who have difficulties reaching the Island.